TRV GP IV’s Revolution Medicines RVMD Stock Holding History

TRV GP IV’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,419,900	Closed	-$33.8M	–	5
2022 Q4	$33.8M	Hold	1,419,900	–	–	14.38%	3
2022 Q3	$28M	Hold	1,419,900	–	–	16.36%	3
2022 Q2	$27.7M	Hold	1,419,900	–	–	18.2%	2
2022 Q1	$36.2M	Hold	1,419,900	–	–	13.27%	3
2021 Q4	$35.7M	Hold	1,419,900	–	–	10.28%	3
2021 Q3	$39.1M	Hold	1,419,900	–	–	8.86%	4
2021 Q2	$45.1M	Hold	1,419,900	–	–	21.46%	3
2021 Q1	$65.1M	Hold	1,419,900	–	–	24%	3
2020 Q4	$56.2M	Hold	1,419,900	–	–	18.03%	3
2020 Q3	$49.4M	Hold	1,419,900	–	–	17.01%	3
2020 Q2	$44.8M	Hold	1,419,900	–	–	20.65%	3
2020 Q1	$31.1M	Buy	+1,419,900	New	+$39.3M	28.44%	2

Other funds holding RVMD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

TRV GP IV's RVMD Position: Q1 2023 in Review

TRV GP IV sold out of Revolution Medicines (RVMD) in Q1 2023, closing a stake of 1,419,900 shares — an estimated $33.8M sold.

TRV GP IV first reported a position in RVMD in Q1 2020 and held it in 12 quarters. The position peaked at $65.1M in Q1 2021. 152 funds tracked by Wall St. Rank hold RVMD as of Q1 2023.

TRV GP IV reported no remaining Revolution Medicines position as of Q1 2023 after selling out during the quarter.
TRV GP IV sold 1,419,900 Revolution Medicines shares in Q1 2023, an estimated $33.8M.
TRV GP IV first reported a position in Revolution Medicines in Q1 2020 and held it in 12 quarters.
TRV GP IV's Revolution Medicines position peaked at $65.1M in Q1 2021.
152 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2023.

Based on TRV GP IV's 13F filing for Q1 2023, filed 12 May 2023.